Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-23T13:14:56.631Z Has data issue: false hasContentIssue false
  • English
  • Français

P0184 - Lipoprotein a levels in recent onset panic disorder. Relationship with clinical severity and treatment response

Published online by Cambridge University Press:  16 April 2020

O. Fernández-Torre ,
A. Herrán ,
M.T. García-Unzueta ,
M.L. Ramírez ,
B. Rodríguez-Cabo ,
F. Hoyuela ,
M. Carrera ,
A. Ayestarán ,
J.L. Vázquez-Barquero  and
J.A. Amado
O. Fernández-Torre
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
A. Herrán
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
M.T. García-Unzueta
Affiliation:
Departamento de Endocrinología, Hospital Universitario Marqués de Valdecilla, Santander, Spain
M.L. Ramírez
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
B. Rodríguez-Cabo
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
F. Hoyuela
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
M. Carrera
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
A. Ayestarán
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
J.L. Vázquez-Barquero
Affiliation:
Departamento de Psiquiatría, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
J.A. Amado
Affiliation:
Departamento de Endocrinología, Hospital Universitario Marqués de Valdecilla, Santander, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It has been shown the relationship between Panic Disorder (PD) and cardiovascular mortality. Lipoprotein (a) is a well known cardiovascular risk factor. The aim of this study was to establish the relationship between Lp (a) and clinical severity in Panic Disorder patients and changes related to treatment response.

Patients with recent onset Panic Disorder were recruited in the Panic Disorder Unit of Cantabria. All of them were drug naive to minimize potential confounding factors. Thereafter, patients entered in a naturalistic treatment with SSRIs and were evaluated after 8 weeks follow-up.

159 patients were included. The mean score of the CGI was of 4.2 ± 1.0 and the mean of Lp (a) levels was 25.0 ± 26.8 mg/dl. Clinical response occurred in about 80% of the patients.

There was a significant correlation between the CGI scale and the Lp (a) levels (rho: 0.208; d.f.: 147; p=0.011) at intake.

Evaluation of Lp (a) at follow up showed lower levels, without statistical significance. Only in the subgroup of patients without agoraphobia this diminution in Lp (a) was significant (p=0.047).

Conclusions:

Patients with higher scores in CGI presented higher levels of Lp (a) with a linear positive correlation between this variables. These findings could implicate Lp (a) in the increased cardiovascular morbidity and mortality in PD.

At follow-up a trend toward decrease in Lp (a) was observed, being this reduction higher in patients without agoraphobia.

Future researches are needed to establish whether Lp (a) modifications occur at longer follow-up evaluations.

Type
Poster Session III: Panic Disorders
Information
European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S354 - S355
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.